Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent (R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea and snoring. The ...

Brisbane, April 4, 2017 AEST (ABN Newswire) - Oventus Medical Ltd (ASX:OVN) are pleased to provide the Company's latest Investor Update. - Oventus Manufacturing receives Certificate of Registration ...

IRVINE, Calif. – Oventus Medical has reported interim financial results for the six months ended Dec. 31, 2021, including $554,000 in revenue. The company, which makes the O2Vent oral device to treat ...

Study Objectives An optional accessory for the O2Vent Optima mandibular advancement device, the ExVent, provides oral expiratory positive airway pressure (EPAP). Similar to nasal EPAP, oral EPAP ...

Brisbane, July 12, 2017 AEST (ABN Newswire) - Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has received FDA 510k clearance for its O2Vent W device, an oral appliance intended to ...

Australia-based medical device company Oventus Medical will unveil its O2Vent flagship product in the US later this month to treat snoring and sleep apnoea. Cleared by the US Food and Drug ...

Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent(R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea (OSA) and snoring.

Oventus Medical Ltd (ASX:OVN) is pleased to announce the launch of the O2Vent(R) Optima device in Australia, an important addition to the Company's sleep treatment platform. Key points: - New Oventus ...